BIT’s 17th Annual International Congress of
Drug Discovery Science & Technology 2019
Theme: The Disruptive, Integrate, Innovation and Development
Time: November 15-17, 2019
Place: Nanjing, China |
Important Activities |
Scientific Program |
|||||||||
Scientific Program |
||
Stream 4 Keynote Forum �� |
||
Time |
FaceOn |
Speeches and Speakers |
Moderator |
Dr. Yinsheng Zhang, Vice President of Pharmaceutical R & D Institute, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, China Tianqing Pharmaceutical Group Co., Ltd, China |
|
13:30-13:35 |
Moderator's Introduction |
|
13:35-14:00 | ![]() |
Title: From Basic Science to Modern Medicine |
14:00-14:20 |
|
Dr. Maode Lai |
14:20-14:40 |
|
Title: Development of CD33 Chimeric Antigen Receptor (CAR) T Cell Therapy Against R/R Acute Myeloid Leukemia (AML) |
14:40-15:00 |
|
Title: Challenge for Drug Discovery in Japan: Open Innovation and Network |
15:00-15:20 |
|
Title: Protein-ligand Interactions: Quantum Mechanical Approach |
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.